Loading…

Alemtuzumab-associated diffuse alveolar damage – a case report

Background Identifying causes of alemtuzumab induced respiratory symptoms in Multiple Sclerosis (MS) patients is crucial. Case presentation We report a case of diffuse alveolar damage (DAD) in a patient with MS after the first course of alemtuzumab treatment. A 42-year-old female developed progressi...

Full description

Saved in:
Bibliographic Details
Published in:BMC neurology 2020-09, Vol.20 (1), p.1-357, Article 357
Main Authors: Bayas, Antonios, Menacher, Martina, Schwaiblmair, Martin, Märkl, Bruno, Naumann, Markus
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Identifying causes of alemtuzumab induced respiratory symptoms in Multiple Sclerosis (MS) patients is crucial. Case presentation We report a case of diffuse alveolar damage (DAD) in a patient with MS after the first course of alemtuzumab treatment. A 42-year-old female developed progressive non-productive cough and exertional dyspnea 2 months after alemtuzumab treatment. DAD was diagnosed histopathologically by lung biopsy. The patient recovered completely, alemtuzumab was not continued. Conclusions Our case highlights another pathomechanism for non-infective lung-disorders in alemtuzumab treated MS patients. DAD is a potential, albeit rare side effect of alemtuzumab, broadening the spectrum of non-infective lung disorders that should be considered in the diagnostic work-up. Keywords: Multiple sclerosis, Alemtuzumab, Diffuse alveolar damage, Case report
ISSN:1471-2377
1471-2377
DOI:10.1186/s12883-020-01934-7